Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127623231 | 12762323 | 1 | I | 201608 | 20160916 | 20160920 | 20160920 | EXP | US-GLAXOSMITHKLINE-US2016136070 | GLAXOSMITHKLINE | 55.14 | YR | F | Y | 0.00000 | 20160920 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127623231 | 12762323 | 1 | PS | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 2 PUFF(S), VA | 20983 | 2 | DF | ||||||||
| 127623231 | 12762323 | 2 | SS | ALBUTEROL. | ALBUTEROL | 1 | 20983 | ||||||||||||
| 127623231 | 12762323 | 3 | C | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 4 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 5 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 6 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 7 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 8 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 10 | C | METOLAZONE. | METOLAZONE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 11 | C | OXYGEN. | OXYGEN | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 12 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 127623231 | 12762323 | 13 | C | VALSARTAN. | VALSARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127623231 | 12762323 | 1 | Asthma |
| 127623231 | 12762323 | 2 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127623231 | 12762323 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127623231 | 12762323 | Dyspnoea | |
| 127623231 | 12762323 | Fluid overload | |
| 127623231 | 12762323 | Micturition frequency decreased | |
| 127623231 | 12762323 | Overdose | |
| 127623231 | 12762323 | Oxygen saturation decreased | |
| 127623231 | 12762323 | Productive cough | |
| 127623231 | 12762323 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |